BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kaźmierska J. Do we protect or discriminate? Representation of senior adults in clinical trials. Rep Pract Oncol Radiother 2012;18:6-10. [PMID: 24381741 DOI: 10.1016/j.rpor.2012.08.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Hjelmeland IHH, Drageset J, Nordvik Ø, Beisland EG. Quality of life in home-dwelling cancer patients aged 80 years and older: a systematic review. Health Qual Life Outcomes 2022;20:154. [DOI: 10.1186/s12955-022-02070-1] [Reference Citation Analysis]
2 Haase KR, Sattar S, Pilleron S, Lambrechts Y, Hannan M, Navarrete E, Kantilal K, Newton L, Kantilal K, Jin R, van der Wal-huisman H, Strohschein FJ, Pergolotti M, Read KB, Kenis C, Puts M. A scoping review of ageism towards older adults in cancer care. Journal of Geriatric Oncology 2022. [DOI: 10.1016/j.jgo.2022.09.014] [Reference Citation Analysis]
3 Hagège M, Canouï-Poitrine F, Derbez B. Including older patients in cancer trials: A qualitative study of collaboration between geriatricians and oncologists. J Geriatr Oncol 2021;12:945-51. [PMID: 33714724 DOI: 10.1016/j.jgo.2021.03.002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Florisson S, Aagesen EK, Bertelsen AS, Nielsen LP, Rosholm JU. Are older adults insufficiently included in clinical trials?-An umbrella review. Basic Clin Pharmacol Toxicol 2021;128:213-23. [PMID: 33210799 DOI: 10.1111/bcpt.13536] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
5 Hamilton JA, Henry CJ. Aging and immunotherapies: New horizons for the golden ages. Aging and Cancer 2020;1:30-44. [DOI: 10.1002/aac2.12014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
6 Sedrak MS, Mohile SG, Sun V, Sun C, Chen BT, Li D, Wong AR, George K, Padam S, Liu J, Katheria V, Dale W. Barriers to clinical trial enrollment of older adults with cancer: A qualitative study of the perceptions of community and academic oncologists. Journal of Geriatric Oncology 2020;11:327-34. [DOI: 10.1016/j.jgo.2019.07.017] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 11.5] [Reference Citation Analysis]
7 Tack L, Lefebvre T, Lycke M, Pottel L, Cool L, Ketelaars L, De Zutter J, Martens E, Pottel H, Stellamans K, Van Eygen K, Werbrouck P, Vergauwe P, Wildiers H, Schofield P, Boterberg T, Debruyne PR. Underrepresentation of vulnerable older patients with cancer in phase II and III oncology registration trials: A case-control study. Journal of Geriatric Oncology 2020;11:320-6. [DOI: 10.1016/j.jgo.2019.09.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
8 Ecarnot F, Meunier-Beillard N, Quenot JP, Meneveau N. Factors associated with refusal or acceptance of older patients (≥ 65 years) to provide consent to participate in clinical research in cardiology: a qualitative study. Aging Clin Exp Res 2020;32:133-40. [PMID: 30903598 DOI: 10.1007/s40520-019-01172-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
9 Dagher M, Sabidó M, Zöllner Y. Effect of age on the effectiveness of the first-line standard of care treatment in patients with metastatic colorectal cancer: systematic review of observational studies. J Cancer Res Clin Oncol 2019;145:2105-14. [PMID: 31201484 DOI: 10.1007/s00432-019-02948-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
10 Dao D, Zemla T, Jatoi A, Freedman RA, Hurria A, Muss H, Cohen HJ, Shulman LN, Citron M, Budman D, McMurray R, Partridge A, Carey L, Sedrak MS, Lafky JM, Le-Rademacher JG. Older-Patient-Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715). Oncologist 2019;24:e284-91. [PMID: 30975921 DOI: 10.1634/theoncologist.2018-0803] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Allum W, Lordick F, Alsina M, Andritsch E, Ba-Ssalamah A, Beishon M, Braga M, Caballero C, Carneiro F, Cassinello F, Dekker JW, Delgado-Bolton R, Haustermans K, Henning G, Hutter B, Lövey J, Netíková IŠ, Obermannová R, Oberst S, Rostoft S, Saarto T, Seufferlein T, Sheth S, Wynter-Blyth V, Costa A, Naredi P. ECCO essential requirements for quality cancer care: Oesophageal and gastric cancer. Crit Rev Oncol Hematol 2018;122:179-93. [PMID: 29458786 DOI: 10.1016/j.critrevonc.2017.12.019] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
12 Maia MC, Adashek J, Bergerot P, Almeida L, Dos Santos SF, Pal SK. Current systemic therapies for metastatic renal cell carcinoma in older adults: A comprehensive review. J Geriatr Oncol 2018;9:265-74. [PMID: 29249644 DOI: 10.1016/j.jgo.2017.11.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
13 Andritsch E, Beishon M, Bielack S, Bonvalot S, Casali P, Crul M, Delgado-bolton R, Donati DM, Douis H, Haas R, Hogendoorn P, Kozhaeva O, Lavender V, Lovey J, Negrouk A, Pereira P, Roca P, de Lempdes GR, Saarto T, van Berck B, Vassal G, Wartenberg M, Yared W, Costa A, Naredi P. ECCO Essential Requirements for Quality Cancer Care: Soft Tissue Sarcoma in Adults and Bone Sarcoma. A critical review. Critical Reviews in Oncology/Hematology 2017;110:94-105. [DOI: 10.1016/j.critrevonc.2016.12.002] [Cited by in Crossref: 69] [Cited by in F6Publishing: 57] [Article Influence: 13.8] [Reference Citation Analysis]
14 Beets G, Sebag-montefiore D, Andritsch E, Arnold D, Beishon M, Crul M, Dekker JW, Delgado-bolton R, Fléjou J, Grisold W, Henning G, Laghi A, Lovey J, Negrouk A, Pereira P, Roca P, Saarto T, Seufferlein T, Taylor C, Ugolini G, Velde CVD, Herck BV, Yared W, Costa A, Naredi P. ECCO Essential Requirements for Quality Cancer Care: Colorectal Cancer. A critical review. Critical Reviews in Oncology/Hematology 2017;110:81-93. [DOI: 10.1016/j.critrevonc.2016.12.001] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 8.6] [Reference Citation Analysis]
15 Smyth EC, Tarazona N, Peckitt C, Armstrong E, Mansukhani S, Cunningham D, Chau I. Exclusion of Gastrointestinal Cancer Patients With Prior Cancer From Clinical Trials: Is This Justified? Clin Colorectal Cancer 2016;15:e53-9. [PMID: 26747392 DOI: 10.1016/j.clcc.2015.11.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
16 Hurria A, Levit LA, Dale W, Mohile SG, Muss HB, Fehrenbacher L, Magnuson A, Lichtman SM, Bruinooge SS, Soto-perez-de-celis E, Tew WP, Postow MA, Cohen HJ. Improving the Evidence Base for Treating Older Adults With Cancer: American Society of Clinical Oncology Statement. JCO 2015;33:3826-33. [DOI: 10.1200/jco.2015.63.0319] [Cited by in Crossref: 259] [Cited by in F6Publishing: 270] [Article Influence: 37.0] [Reference Citation Analysis]
17 Petera J, Dušek L, Sirák I, Soumarova R, Jarkovsky J. Cancer in the elderly in the Czech Republic: Cancer in the elderly in the Czech Republic. Eur J Cancer Care (Engl) 2015;24:163-78. [DOI: 10.1111/ecc.12287] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
18 Lach M, Trzeciak T, Richter M, Pawlicz J, Suchorska WM. Directed differentiation of induced pluripotent stem cells into chondrogenic lineages for articular cartilage treatment. J Tissue Eng 2014;5:2041731414552701. [PMID: 25383175 DOI: 10.1177/2041731414552701] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
19 Petera J, Dušek L. Cancer in the elderly. Rep Pract Oncol Radiother 2012;18:1-5. [PMID: 24381740 DOI: 10.1016/j.rpor.2012.11.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]